C3-targeted therapy in periodontal disease: moving closer to the clinic

Medicine and Dentistry

• Clinical Study 33%
• Clinical Trial 33%
• Gingivitis 33%
• Homeostasis 33%
• Immunosurveillance 33%
• Inflammatory Disorder 33%
• Periodontal Disease 100%
• Periodontitis 66%
• Pharmacokinetics 33%
• Targeted Therapy 100%

Immunology and Microbiology

• Gingivitis 50%
• Homeostasis 50%
• Immunosurveillance 50%
• Inflammatory Disorder 50%
• Periodontitis 100%
• Pharmacokinetics 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Clinical Study 33%
• Clinical Trial 33%
• Gingivitis 33%
• Periodontal Disease 100%
• Periodontitis 66%
• Pharmacokinetics 33%